Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Neonatal Opiate Withdrawal Syndrome clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Neonatal Opiate Withdrawal Syndrome: 1 US clinical trial tracked, none currently recruiting.

Neonatal Opiate Withdrawal Syndrome is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is T. John Winhusen, PhD, running 1 of these trials.

Enrollment posture brief

Registry condition neonatal-opiate-withdrawal-syndrome

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Neonatal Opiate Withdraw (th…0%
Open-enrollment share among volume-matched conditions near Neonatal Opiate Withdrawal Syndrome

Neonatal Opiate Withdrawal Syndrome has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Neonatal Opiate Withdrawal Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Neonatal Opiate Withdrawal Syndrome is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Neonatal Opiate Withdrawal Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Buprenorphine Sublingual Product Drug
1 trials
Buprenorphine Injection Drug
1 trials

US sites by state

Facility locations filed on Neonatal Opiate Withdrawal Syndrome trials. A trial with sites in several states counts in each.

West Virginia 1 trials
Washington 1 trials
Utah 1 trials
Tennessee 1 trials
South Carolina 1 trials
Pennsylvania 1 trials
Oregon 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Neonatal Opiate Withdrawal Syndrome page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Neonatal Opiate Withdrawal Syndrome trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • T. John Winhusen, PhD sponsors the most Neonatal Opiate Withdrawal Syndrome trials on record, review their full trial history before evaluating a specific study. See T. John Winhusen, PhD's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neonatal Opiate Withdrawal Syndrome condition card totals 1 registered trials; most-linked intervention Buprenorphine Sublingual Product; top US site state West Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.